biguanides has been researched along with Drug Withdrawal Symptoms in 3 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Present study investigated the role of agmatine in ethanol-induced anxiolysis and withdrawal anxiety using elevated plus maze (EPM) test in rats." | 7.76 | Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. ( Chopde, CT; Kotagale, NR; Patel, MR; Shelkar, GP; Taksande, BG; Ugale, RR, 2010) |
| "Present study investigated the role of agmatine in ethanol-induced anxiolysis and withdrawal anxiety using elevated plus maze (EPM) test in rats." | 3.76 | Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. ( Chopde, CT; Kotagale, NR; Patel, MR; Shelkar, GP; Taksande, BG; Ugale, RR, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taksande, BG | 1 |
| Kotagale, NR | 1 |
| Patel, MR | 1 |
| Shelkar, GP | 1 |
| Ugale, RR | 1 |
| Chopde, CT | 1 |
| Siitonen, O | 1 |
| Aro, A | 1 |
| Huttunen, JK | 1 |
| Juvonen, H | 1 |
| Järvinen, R | 1 |
| Korhonen, T | 1 |
| Palomäki, P | 1 |
| Ritala, P | 1 |
| Matell, MS | 1 |
| King, GR | 1 |
3 other studies available for biguanides and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
Topics: Agmatine; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Biguanides; Brain; Clonidine; Dose-Respon | 2010 |
Effect of discontinuation of biguanide therapy on metabolic control in maturity-onset diabetics.
Topics: Aged; Biguanides; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Female; | 1980 |
5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine.
Topics: Animals; Biguanides; Cocaine; Dopamine; Male; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawl | 1997 |